Pages that link to "Q43542493"

The following pages link to A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity (Q43542493):

Displaying 43 items.

• Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. (Q24799062) (← links)
• 'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies (Q28221639) (← links)
• Genetic variants associated with fasting blood lipids in the U.S. population: Third National Health and Nutrition Examination Survey (Q28395880) (← links)
• The genetics of obesity. (Q30336529) (← links)
• The association between the Pro12Ala variant in the PPARγ2 gene and type 2 diabetes mellitus and obesity in a Chinese population (Q31132059) (← links)
• PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes (Q33461994) (← links)
• Impact of genetic variation of PPARgamma in humans (Q34355553) (← links)
• Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. (Q34406470) (← links)
• Genetic determinants of type 2 diabetes mellitus (Q34421519) (← links)
• Genetics of leptin and obesity: a HuGE review (Q34428366) (← links)
• Comparing nuclear receptors in worms, flies and humans (Q34455095) (← links)
• The human obesity gene map: the 2001 update (Q34557274) (← links)
• Peroxisome proliferator activated receptors and obesity (Q34635500) (← links)
• Association of the variants in the PPARG gene and serum lipid levels: a meta-analysis of 74 studies. (Q34885498) (← links)
• Relationship of APOA5, PPARγ and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood. (Q35061151) (← links)
• Human nutrition and food research: opportunities and challenges in the post-genomic era (Q35213745) (← links)
• Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk (Q35643886) (← links)
• Nuclear receptor variants in liver disease (Q35864839) (← links)
• Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels (Q36430298) (← links)
• PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility. (Q36465006) (← links)
• PPARγ2 polymorphism and human health (Q37159796) (← links)
• Nutrigenomic Functions of PPARs in Obesogenic Environments. (Q37500797) (← links)
• PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han population (Q37528000) (← links)
• Effect of the Pro12Ala Polymorphism of the Peroxisome Proliferator-activated Receptor γ2 Gene on Lipid Profile and Adipokines Levels in Obese Subjects (Q41155800) (← links)
• Interaction between PPARgamma2 variants and gender on the modulation of body weight. (Q42650939) (← links)
• The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene in relation to obesity and metabolic phenotypes in a Taiwanese population (Q43704491) (← links)
• Pro12Ala polymorphism in human peroxisome proliferator activated receptor gamma is associated with hyperlipidaemia in obstructive sleep apnoea hypopnoea syndrome (Q43953982) (← links)
• Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population (Q44210344) (← links)
• Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study (Q44332739) (← links)
• Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation (Q44452896) (← links)
• Alcohol intake modulates the genetic association between HDL cholesterol and the PPARgamma2 Pro12Ala polymorphism (Q45270124) (← links)
• Associations between the components of metabolic syndrome and the polymorphisms in the peroxisome proliferator-activated receptor gamma (PPAR-γ), the fat mass and obesity-associated (FTO), and the melanocortin-4 receptor (MC4R) genes (Q47218578) (← links)
• PPARγ2 gene Pro12Ala and PPARα gene Leu162Val single nucleotide polymorphisms interact with dietary intake of fat in determination of plasma lipid concentrations (Q49169034) (← links)
• Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers (Q49235575) (← links)
• Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: A meta-analysis (Q51383684) (← links)
• Impact of the PPAR gamma-2 gene polymorphisms on the metabolic state of postmenopausal women. (Q51539637) (← links)
• [Obesity studies in candidate genes]. (Q52372230) (← links)
• Association between peroxisome proliferator-activated receptor-γ gene polymorphism (Pro12Ala) and Helicobacter pylori infection in gastric carcinogenesis. (Q53297929) (← links)
• Association of PPAR-γ gene polymorphisms with obesity and obesity-associated phenotypes in North Indian population. (Q54319581) (← links)
• Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes (Q61945788) (← links)
• The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects (Q84113524) (← links)
• Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover (Q90666935) (← links)
• ASSOCIATION OF THE HUMAN PPARγ2 PRO12ALA POLYMORPHISM WITH OBESITY IN A POPULATION FROM TURKEY (Q92432629) (← links)